Skip to content

Comparison of Dry Needling and Foam Rolling on Calf Tightness.

Acute effects of Gastro-soleus Self myofascial Release Versus Dry Needling on Closed Chain Dorsiflexion Range and Muscle Performance.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/039950
Enrollment
36
Registered
2022-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Self-myofascial release (SMR) and Dry needling: Group A-SMR using Foam Roller Group-Using a foam roller(45 sec,5 reps) Group B-Dry Needling(two needles in the medial head and two needle

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Normal Individuals with a weight bearing lunge test value of less or equal to 6 cm 2.Active or Latent Trigger point over calf muscles 3.Individuals with the ability to understand the study and the informed consent, as well as having signed the consent form

Exclusion criteria

Exclusion criteria: 1.Needle phobia 2.Needle allergy or hypersensitivity to metals 3.The presence of coagulopathy or use of anticoagulants according to medical criteria 4.The presence of peripheral arterial vascular disease 5.Pregnancy 6.Dermatological disease affecting the DN area; 7.The presence of any chronic medical condition which might preclude participation in the study, such as malignancy, systemic inflammatory disorders (e.g., rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, septic arthritis), neurological diseases, polyneuropathy, mononeuropathy.

Design outcomes

Primary

MeasureTime frame
1.Closed Chain Dorsiflexion Range-Weight bearing Lunge Test 2.Muscle Performance-Heel Raises 3.Pain-Visual Analog Scale 4.Lateral Step-Down Test 5.Range of Motion Timepoint: All the outcome measures will be measured pre and post intervention after one time application of treatment.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactPratiksha Hegde

Sunandan Divatia School of Science,NMIMS University

pratikshahegde1997@gmail.com8600249170

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026